Macrogenics (MGNX) Cost of Revenue (2021 - 2024)
Macrogenics (MGNX) reported Cost of Revenue of $233000.0 for Q4 2024, up 42.94% year-over-year from $163000.0 in Q1 2024, and up 38.69% quarter-over-quarter from $168000.0 in Q3 2024.
Macrogenics (MGNX) Cost of Revenue (2021 - 2024) Analysis & Trends
Macrogenics (MGNX) has 4 years of Cost of Revenue data on file, last reported at $233000.0 in Q4 2024.
- Cost of Revenue for Q4 2024 came in at $233000.0, up 42.94% year-over-year; the trailing twelve-month figure through Sep 2025 was $233000.0 (down 70.01% YoY), and the FY2024 annual result was $847000.0, up 36.83% from the prior year.
- Cost of Revenue rose to $233000.0 in Q4 2024 per MGNX's latest filing, from $168000.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $3.0 million in Q3 2022 and troughed at $17000.0 in Q1 2021.
- A 4-year average of $466750.0 and a median of $172000.0 in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue soared 718.18% in 2022, then slumped 97.17% in 2023.
- A 4-year view of Cost of Revenue shows it stood at $947000.0 in 2021, then slumped by 87.75% to $116000.0 in 2022, then surged by 40.52% to $163000.0 in 2023, then jumped by 42.94% to $233000.0 in 2024.
- Business Quant data shows MGNX's Cost of Revenue at $233000.0 in Q4 2024, $168000.0 in Q3 2024, and $176000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 233,000.00 |
| Dec 31, 2024 | 233,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 270,000.00 |
| Mar 31, 2024 | 270,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | 258,000.00 |
| Jun 30, 2023 | 258,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 3.01 Mn |
| Sep 30, 2022 | 3.01 Mn |